Together with the reports that CDK8/19 inhibition suppresses the replication of other viruses [44,45,46], our findings suggest that CDK8/19 inhibitors may be broadly beneficial for the treatment of different viral and bacterial infections and potential immunomodulators. This evidence concerns the gene CDK8 and bacterial infectious disease.